| 2008n = 158 916 | 2010n = 169 178 | 2012n = 188 073 | 2014n = 244 390 | 2016n = 261 283 | 2018n = 190 528 | |
|---|---|---|---|---|---|---|
| Men, n (%) | 75 694 (47.6) | 80 777 (47.7) | 89 986 (47.8) | 117 063 (47.9) | 125 514 (48.0) | 92 078 (48.3) |
| Mean age, years (SD) | 45.5 (17.1) | 45.7 (17.2) | 46.1 (17.3) | 46.4 (17.6) | 46.2 (17.6) | 46.2 (17.8) |
| Previous CVD, n (%) | 9394 (5.9) | 11 255 (6.7) | 13 226 (7.0) | 16 965 (6.9) | 18 974 (7.3) | 13 852 (7.3) |
| DM, n (%) | 8976 (5.6) | 10 640 (6.3) | 12 345 (6.6) | 15 766 (6.5) | 17 478 (6.7) | 12 786 (6.7) |
| CVD and DM, n (%) | 2205 (1.4) | 2846 (1.7) | 3460 (1.8) | 4553 (1.9) | 5188 (2.0) | 3732 (2.0) |
| CRA indication,a n (%) | 25 355 (16.0) | 32 054 (18.9) | 39 882 (21.2) | 53 391 (21.8) | 61 000 (23.3) | 45 759 (24.0) |
aPatients were classified as ‘CRA indication’ if they had no history of CVD or DM, but did have a history of one of the following: rheumatoid arthritis, pre-eclampsia, pregnancy-induced DM, family history of CVD, obesity, smoking, hypertension, dyslipidaemia, chronic kidney disease, use of antihypertensive or lipid-lowering medication.
DM = diabetes mellitus. CRA = cardiovascular risk assessment. CVD = cardiovascular disease. SD = standard deviation.